Post-Transplant Cyclophosphamide Allows Allogeneic Hematopoietic Stem-Cell Transplantation Across Donor Types for Nonmalignant Hematologic Diseases
Journal of Hematology · 2026-04 · 15 (2) · 71-79
DOI: 10.14740/jh2184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematology, 2026-04. Verfasst von Baldeep Wirk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Immunotherapies and Transplant Program, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cellular Immunotherapies and Transplant Program, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
- Department of Biostatistics, School of Public Health, Virginia Commonwealth University, Richmond, VA, USA.
ORCID-Profile: Baldeep Wirk
Zitieren
APA
Wirk, B., & Deng, X. (2026). Post-Transplant Cyclophosphamide Allows Allogeneic Hematopoietic Stem-Cell Transplantation Across Donor Types for Nonmalignant Hematologic Diseases. Journal of Hematology, 15(2), 71-79. https://doi.org/10.14740/jh2184
Vancouver
Wirk B, Deng X. Post-Transplant Cyclophosphamide Allows Allogeneic Hematopoietic Stem-Cell Transplantation Across Donor Types for Nonmalignant Hematologic Diseases. Journal of Hematology. 2026;15(2):71-79. doi:10.14740/jh2184
BibTeX
@article{Wirk2026,
author = {Wirk, Baldeep and Deng, Xiaoyan},
title = {Post-Transplant Cyclophosphamide Allows Allogeneic Hematopoietic Stem-Cell Transplantation Across Donor Types for Nonmalignant Hematologic Diseases},
journal = {Journal of Hematology},
year = {2026},
volume = {15},
number = {2},
pages = {71--79},
doi = {10.14740/jh2184}
}
EUVIMED